PTHrP treatment fails to rescue bone defects caused by hedgehog pathway inhibition in young mice

Toxicologic Pathology

Volumn 39, Issue 3, 2011, Pages 478-485

  Brechbiel, Jillian L ^a   Ng, Jessica M Y ^a   Curran, Tom ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

chondrocytes; Hedgehog pathway; HhAntag; medulloblastoma; PTHrP

Indexed keywords

ANTINEOPLASTIC AGENT; H 5494; HEDGEHOG INHIBITOR; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN[1-37]; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; GROWTH PLATE; GROWTH PLATE FUSION; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; TRABECULAR BONE;

ANIMALS; CELL DIFFERENTIATION; CHONDROCYTES; FEMALE; GROWTH PLATE; HEDGEHOG PROTEINS; MICE; MOLECULAR TARGETED THERAPY; PARATHYROID HORMONE-RELATED PROTEIN; PREGNANCY; SIGNAL TRANSDUCTION;

ERINACEIDAE; MUS;

EID: 79955552076     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311399788     Document Type: Article

References (42)

1. Adams S. L., Cohen A. J., Lassova L.. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J Cell Physiol. 2007 ; 213: 635-41 (Pubitemid 350058255)
2. Chung U. I., Schipani E., McMahon A. P., Kronenberg H. M.. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest. 2001 ; 107: 295-304 (Pubitemid 32157961)
3. Curran T., Ng J. M.. Cancer: Hedgehog's other great trick. Nature. 2008 ; 455: 293-94
4. Day T. F., Guo X., Garrett-Beal L., Yang Y.. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005 ; 8: 739-50 (Pubitemid 40585296)
5. Dellovade T., Romer J. T., Curran T., Rubin L. L.. The hedgehog pathway and neurological disorders. Annu Rev Neurosci. 2006 ; 29: 539-63 (Pubitemid 44476855)
6. Ecke I., Rosenberger A., Obenauer S., Dullin C., Aberger F., Kimmina S., Schweyer S., Hahn H.. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth. Mol Carcinog. 2008 ; 47: 361-72 (Pubitemid 351614576)
7. Erlebacher A., Filvaroff E. H., Gitelman S. E., Derynck R.. Toward a molecular understanding of skeletal development. Cell. 1995 ; 80: 371-78
8. Frank-Kamenetsky M., Zhang X. M., Bottega S., Guicherit O., Wichterle H., Dudek H., Bumcrot D., Wang F. Y., Jones S., Shulok J., Rubin L. L., Porter J. A.. Small-molecule modulators of Hedgehog signaling: Identification and characterization of Smoothened agonists and antagonists. J Biol. 2002 ; 1: 10
9. Hahn H., Wicking C., Zaphiropoulous P. G., Gailani M. R., Shanley S., Chidambaram A., Vorechovsky I., Holmberg E., Unden A. B., Gillies S., Negus K., Smyth I., Pressman C., Leffell D. J., Gerrard B., Goldstein A. M., Dean M., Toftgard R., Chenevix-Trench G., Wainwright B., Bale A. E.. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996 ; 85: 841-51 (Pubitemid 26192135)
10. Johnson R. L., Rothman A. L., Xie J., Goodrich L. V., Bare J. W., Bonifas J. M., Quinn A. G., Myers R. M., Cox D. R., Epstein E. H., Scott M. P.. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996 ; 272: 1668-71 (Pubitemid 26200029)
11. Karp S. J., Schipani E., St-Jacques B., Hunzelman J., Kronenberg H., McMahon A. P.. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development. 2000 ; 127: 543-48 (Pubitemid 30093402)
12. Kimura H., Ng J. M., Curran T.. Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell. 2008 ; 13: 249-60 (Pubitemid 351324879)
13. Kobayashi T., Soegiarto D. W., Yang Y., Lanske B., Schipani E., McMahon A. P., Kronenberg H. M.. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest. 2005 ; 115: 1734-42 (Pubitemid 40979712)
14. Lanske B., Karaplis A. C., Lee K., Luz A., Vortkamp A., Pirro A., Karperien M., Defize L. H., Ho C., Mulligan R. C., Abou-Samra A. B., Juppner H., Segre G. V., Kronenberg H. M.. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science. 1996 ; 273: 663-66 (Pubitemid 26262123)
15. Lee K., Lanske B., Karaplis A. C., Deeds J. D., Kohno H., Nissenson R. A., Kronenberg H. M., Segre G. V.. Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology. 1996 ; 137: 5109-18 (Pubitemid 26403356)
16. Louis D. N., Ohgaki H., Wiestler O. D., Cavenee W. K., Burger P. C., Jouvet A., Scheithauer B. W., Kleihues P.. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007 ; 114: 97-109 (Pubitemid 47103521)
17. Maeda Y., Nakamura E., Nguyen M. T., Suva L. J., Swain F. L., Razzaque M. S., Mackem S., Lanske B.. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci U S A. 2007 ; 104: 6382-87 (Pubitemid 47186103)
18. Maeda Y., Schipani E., Densmore M. J., Lanske B.. Partial rescue of postnatal growth plate abnormalities in Ihh mutants by expression of a constitutively active PTH/PTHrP receptor. Bone. 2009 ; 46: 472-78
19. Mak K. K., Kronenberg H. M., Chuang P. T., Mackem S., Yang Y.. Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development. 2008 ; 135: 1947-56 (Pubitemid 351943359)
20. McMahon A. P., Ingham P. W., Tabin C. J.. Developmental roles and clinical significance of hedgehog signalling. Curr Top Dev Biol. 2003 ; 53: 1-114 (Pubitemid 137639458)
21. Minina E., Wenzel H. M., Kreschel C., Karp S., Gaffield W., McMahon A. P., Vortkamp A.. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development. 2001 ; 128: 4523-34 (Pubitemid 33130432)
22. Murone M., Rosenthal A., de Sauvage F. J.. Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr Biol. 1999 ; 9: 76-84 (Pubitemid 29083531)
23. Ornitz D. M., Marie P. J.. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002 ; 16: 1446-65 (Pubitemid 34686327)
24. Robarge K. D., Brunton S. A., Castanedo G. M., Cui Y., Dina M. S., Goldsmith R., Gould S. E., Guichert O., Gunzner J. L., Halladay J., Jia W., Khojasteh C., Koehler M. F., Kotkow K., La H., Lalonde R. L., Lau K., Lee L., Marshall D., Marsters J. C., Murray L. J., Qian C., Rubin L. L., Salphati L., Stanley M. S., Stibbard J. H., Sutherlin D. P., Ubhayaker S., Wang S., Wong S., Xie M.. GDC-0449-a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett. 2009 ; 19: 5576-81
25. Rohatgi R., Milenkovic L., Scott M. P.. Patched1 regulates hedgehog signaling at the primary cilium. Science. 2007 ; 317: 372-76 (Pubitemid 47106377)
26. Romer J., Curran T.. Targeting medulloblastoma: Small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res. 2005 ; 65: 4975-78 (Pubitemid 40827300)
27. Romer J. T., Kimura H., Magdaleno S., Sasai K., Fuller C., Baines H., Connelly M., Stewart C. F., Gould S., Rubin L. L., Curran T.. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell. 2004 ; 6: 229-40 (Pubitemid 39222036)
28. Rominger C. M., Bee W. L., Copeland R. A., Davenport E. A., Gilmartin A., Gontarek R., Hornberger K. R., Kallal L. A., Lai Z., Lawrie K., Lu Q., McMillan L., Truong M., Tummino P. J., Turunen B., Will M., Zuercher W. J., Rominger D. H.. Evidence for allosteric interactions of antagonist binding to the smoothened receptor. J Pharmacol Exp Ther. 2009 ; 329: 995-1005
29. Rudin C. M., Hann C. L., Laterra J., Yauch R. L., Callahan C. A., Fu L., Holcomb T., Stinson J., Gould S. E., Coleman B., LoRusso P. M., Von Hoff D. D., de Sauvage F. J., Low J. A.. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009 ; 361: 1173-78
30. Sasai K., Romer J. T., Kimura H., Eberhart D. E., Rice D. S., Curran T.. Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor. Cancer Res. 2007 ; 67: 3871-77 (Pubitemid 46762175)
31. Sasai K., Romer J. T., Lee Y., Finkelstein D., Fuller C., McKinnon P. J., Curran T.. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer Res. 2006 ; 66: 4215-22
32. Scales S. J., de Sauvage F. J.. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci. 2009 ; 30: 303-12
33. Stewart A. F., Cain R. L., Burr D. B., Jacob D., Turner C. H., Hock J. M.. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: A comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. J Bone Miner Res. 2000 ; 15: 1517-25 (Pubitemid 30484521)
34. Theunissen J. W., de Sauvage F. J.. Paracrine Hedgehog signaling in cancer. Cancer Res. 2009 ; 69: 6007-10
35. Tremblay M. R., Nesler M., Weatherhead R., Castro A. C.. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy. Exp Opin Ther Pat. 2009 ; 19: 1039-56
36. Von Hoff D. D., LoRusso P. M., Rudin C. M., Reddy J. C., Yauch R. L., Tibes R., Weiss G. J., Borad M. J., Hann C. L., Brahmer J. R., Mackey H. M., Lum B. L., Darbonne W. C., Marsters J. C., de Sauvage F. J., Low J. A.. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009 ; 361: 1164-72
37. Vortkamp A., Lee K., Lanske B., Segre G. V., Kronenberg H. M., Tabin C. J.. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 1996 ; 273: 613-22 (Pubitemid 26262108)
38. Williams J. A., Guicherit O. M., Zaharian B. I., Xu Y., Chai L., Wichterle H., Kon C., Gatchalian C., Porter J. A., Rubin L. L., Wang F. Y.. Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A. 2003 ; 100: 4616-21 (Pubitemid 36457779)
39. Wong H., Chen J. Z., Chou B., Halladay J. S., Kenny J. R., La H., Marsters J. C., Plise E., Rudewicz P. J., Robarge K., Shin Y., Wong S., Zhang C., Khojasteh S. C.. Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl) phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor. Xenobiotica. 2009 ; 39: 850-61
40. Xue Y., Zhang Z., Karaplis A. C., Hendy G. N., Goltzman D., Miao D.. Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice. J Bone Miner Res. 2005 ; 20: 1766-77 (Pubitemid 41361877)
41. Yauch R. L., Dijkgraaf G. J., Alicke B., Januario T., Ahn C. P., Holcomb T., Pujara K., Stinson J., Callahan C. A., Tang T., Bazan J. F., Kan Z., Seshagiri S., Hann C. L., Gould S. E., Low J. A., Rudin C. M., de Sauvage F. J.. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science. 2009 ; 326: 572-74
42. Yauch R. L., Gould S. E., Scales S. J., Tang T., Tian H., Ahn C. P., Marshall D., Fu L., Januario T., Kallop D., Nannini-Pepe M., Kotkow K., Marsters J. C., Rubin L. L., de Sauvage F. J.. A paracrine requirement for hedgehog signalling in cancer. Nature. 2008 ; 455: 406-10